--- a
+++ b/clusters/9knumclustersv2/clust_1299.txt
@@ -0,0 +1,34 @@
+Other serious, ongoing, non-malignant disease or infection that would compromise protocol objectives
+Medical or psychiatric illnesses that, in the investigator's opinion, may impact the safety of the subject or the objectives of the study.
+Subject requires any medical intervention(s) or has any other condition(s) that, in the Investigators opinion, will ) make the administration of PROSTVAC or ipilimumab hazardous, ) obscure the interpretation of adverse events (AEs), ) compromise adherence with study requirements, or ) otherwise compromise the studys objectives
+Any medical intervention, any other condition, or any other circumstance which, in the opinion of the investigator, could compromise adherence with study requirements or otherwise compromise the studys objectives
+Serious non-malignant disease such as active infection or other condition which in the opinion of the investigator would compromise other protocol objectives
+Any medical intervention or other condition which, in the opinion of the principal investigator, could compromise adherence with study requirements or otherwise compromise the studys objectives
+Significant acute or chronic medical or psychiatric illness that, in the judgment of the Investigator, could compromise subject safety, limit the subject's ability to complete the trial, and/or compromise the objectives of the trial
+Other serious, ongoing, non-malignant disease or infection that would in the opinion of the site investigator compromise other protocol objectives
+hepatic, renal neurological or metabolic conditions - which in the opinion of the investigator would compromise the protocol objectives.
+Any concomitant condition that in the opinion of the investigator could compromise the objectives of this study and the patient's compliance.
+Any other condition or circumstance that could interfere with adherence to the studys procedures or requirements, or otherwise compromise the studys objectives such as history of, or any evidence of active, non-infectious pneumonitis
+Any other current or previous malignancy within the past three years that, in the opinion of the Principal Investigator, will interfere with study-specific objectives.
+Significant acute or chronic medical, neurologic, or psychiatric illness in the subject that, in the judgment of the principal investigator, could compromise subject safety, limit the subjects ability to complete the study, and/or compromise the objectives of the study
+Any concomitant condition that in the opinion of the Investigator could compromise the objectives of this study and the patient's compliance.
+Other condition(s) that in the opinion of the investigator might compromise the objectives of the study
+Patients or their representative who are unable to understand the conditions and objectives of the study
+Other condition(s) that in the opinion of the investigator might compromise the objectives of the study or increase patient risk
+Any medical intervention or other condition which, in the opinion of the principal investigator could compromise adherence with study requirements or otherwise compromise the study's objectives
+Any condition that compromises compliance with the objectives and procedures of this protocol
+Any medical intervention or other condition which, in the opinion of the principal investigator could compromise adherence with study requirements or otherwise compromise the studys objectives
+Any concomitant condition that in the opinion of the investigator could compromise the objectives of this study and the patient's compliance.
+Serious non-malignant disease (e.g., active uncontrolled bacterial, viral, or fungal infections) or other medical conditions (including psychiatric) which, in the opinion of the Principal Investigator (PI) would compromise other protocol objectives
+Have active infection that would interfere with the study objectives or influence study compliance
+Any medical intervention, condition or any other circumstance which in the opinion of the investigator or the sponsor's medical monitor, could compromise adherence to study procedures or study objectives.
+Active alcohol abuse or other illness or circumstance that carries a likelihood of inability to comply with study treatment and follow-up or otherwise compromise the studys objectives
+Patients may not have any concomitant condition that could compromise the objectives of this study and the patients' compliance and ability to tolerate this therapy and complete at least  cycles of therapy, including, but not limited to the following:
+Medical exclusions include: patients with a history of myocardial infarction or ischemic heart disease within the past six months; patients with history of epilepsy, brain damage, or symptomatic brain metastases; skin conditions such as open sores that would prevent proper application of the electrodes; or other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
+Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
+Significant acute or chronic medical, neurologic, or psychiatric illness in the subject that, in the judgment of the principal investigator, could compromise subject safety, limit the subjects ability to complete the study, and/or compromise the objectives of the study
+Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
+Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
+Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
+Any medical condition that in the opinion of the investigators could potentially jeopardize the safety of the patient, limit the patients ability to complete the study, and/or compromise the objectives of the study
+Significant acute or chronic medical, neurologic, or psychiatric illness in the subject that, in the judgment of the investigator, could compromise subject safety, limit the subjects ability to complete the study, and/or compromise the objectives of the study